Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2026

Genmab — Januar 2026

Planlagt Fastgjort Låst Flyttet Genmab
295 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #249

    Sad that Hexabody CD38 did not make it……

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #250

      Just a moment...

      favicon

      (www.fiercebiotech.com)

      1 Reply Last reply
      0
      • Z Offline
        Z Offline
        Zipo
        wrote on sidst redigeret af
        #251

        Er FDA-artiklen en kurs-trigger for Genmab?
        ❌ Kort svar: Nej – ikke i sig selv
        ✅ Længere, præcis vurdering:

        Hvorfor ikke en direkte trigger

        Genmab har ingen egen myelom-studier

        Ingen kommende MRD-readouts

        Ingen regulatoriske events direkte koblet til artiklen

        Hvorfor den alligevel betyder noget

        Forbedrer royalty-option value på BCMA-bispecifics

        Øger strategisk værdi af DuoBody-platformen

        Sænker regulatory risk for myelom-partnerskaber

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #252

          UBS https://x.com/_ShahKruti/status/2014420301191479714

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #253

            RAINFOL-05 (lung) starts recruiting https://clinicaltrials.gov/study/NCT07288177?tab=history&a=2&b=3#version-content-panel

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #254

              New trial sneaking in... : Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT07353957 even started recruiting already...

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #255

                i wonder if will get to see some early data from the Ph I / II solid tumors trial, on the NSCLC arm, Primary Completion was 2025-11 , but hasn't been updated for a long time https://clinicaltrials.gov/study/NCT03526835

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #256

                  this could put the Acasunlimab decision in a different light (and even GEN1286)

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    peter12
                    wrote on sidst redigeret af
                    #257

                    Spændende artikel om Peto https://www.irbbarcelona.org/en/news/scientific/mcla-158-first-clinical-candidate-screened-organoids-targeting-cancer-stem-cells

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #258

                      small new trial City of Hope - Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/​Refractory Diffuse Large B-Cell Lymphoma
                      https://clinicaltrials.gov/study/NCT07365306

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #259

                        small new trial - Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma https://clinicaltrials.gov/study/NCT07332507

                        1 Reply Last reply
                        0
                        • B Offline
                          B Offline
                          bb8
                          wrote on sidst redigeret af
                          #260

                          https://endpoints.news/genmab-halts-enrollment-for-cancer-drug-from-profoundbio-buyout/ Genmab halts enrollment for cancer drug from ProfoundBio buyout

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            ProinvestorNEWS
                            wrote on sidst redigeret af
                            #261

                            Go
                            dmorgen 🙂

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bibob
                              wrote on sidst redigeret af
                              #262

                              God morgen. 🙂

                              1 Reply Last reply
                              0
                              • J Offline
                                J Offline
                                JKY_VH
                                wrote on sidst redigeret af
                                #263

                                Har jeg misset nogle nyheder eller er den bare blevet for billig +1,75% på en studs

                                1 Reply Last reply
                                0
                                • T Offline
                                  T Offline
                                  transalp
                                  wrote on sidst redigeret af
                                  #264

                                  Samme tanke her.. 🙂

                                  1 Reply Last reply
                                  0
                                  • concilladoC Offline
                                    concilladoC Offline
                                    concillado
                                    wrote on sidst redigeret af
                                    #265

                                    Hvornår har aktien ikke været for billig?? 😉

                                    1 Reply Last reply
                                    0
                                    • concilladoC Offline
                                      concilladoC Offline
                                      concillado
                                      wrote on sidst redigeret af
                                      #266

                                      Den ma da gerne falde, når der snart bliver udbetalt udbytte, som skal placeres 😄

                                      1 Reply Last reply
                                      0
                                      • R Offline
                                        R Offline
                                        Raun
                                        wrote on sidst redigeret af
                                        #267

                                        Det ligner en af de dage, hvor US af en eller anden grund handler aktien op

                                        1 Reply Last reply
                                        0
                                        • nohopeN Offline
                                          nohopeN Offline
                                          nohope
                                          wrote on sidst redigeret af
                                          #268

                                          26/1 "Genmab halts enrollment for cancer drug from ProfoundBio buyout" Ingen der har kommentarer til dette ?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper